Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12810867rdf:typepubmed:Citationlld:pubmed
pubmed-article:12810867lifeskim:mentionsumls-concept:C0014047lld:lifeskim
pubmed-article:12810867lifeskim:mentionsumls-concept:C0042769lld:lifeskim
pubmed-article:12810867lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:12810867lifeskim:mentionsumls-concept:C0042542lld:lifeskim
pubmed-article:12810867lifeskim:mentionsumls-concept:C0008286lld:lifeskim
pubmed-article:12810867lifeskim:mentionsumls-concept:C2346501lld:lifeskim
pubmed-article:12810867pubmed:issuePt 7lld:pubmed
pubmed-article:12810867pubmed:dateCreated2003-6-17lld:pubmed
pubmed-article:12810867pubmed:abstractTextEntry of Japanese encephalitis virus (JEV) into cells was analysed by using the vertebrate cell line Vero. Vero cells were treated with chlorpromazine, nystatin or cytochalasin D, which inhibit clathrin- and caveola-dependent endocytosis, and macropinocytosis of the cells, respectively. Productive JEV infection was inhibited by pretreatment with chlorpromazine; the number of JEV antigen-positive cells was less than one-fifth of that in untreated cultures, but was not significantly decreased by pretreatment with nystatin or cytochalasin. Viral antigens were detected in the membrane fractions, but not in the endosome fractions from chlorpromazine-treated JEV-inoculated cells. When the cells were treated with chlorpromazine, clathrin heavy chain antigen and JEV antigen were not detected in cytoplasm by indirect immunofluorescence staining. These results indicate that JEV is taken up by cells through the clathrin-dependent endocytic pathway, and this process leads to infection.lld:pubmed
pubmed-article:12810867pubmed:languageenglld:pubmed
pubmed-article:12810867pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12810867pubmed:citationSubsetIMlld:pubmed
pubmed-article:12810867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12810867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12810867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12810867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12810867pubmed:statusMEDLINElld:pubmed
pubmed-article:12810867pubmed:monthJullld:pubmed
pubmed-article:12810867pubmed:issn0022-1317lld:pubmed
pubmed-article:12810867pubmed:authorpubmed-author:KuraneIchiroIlld:pubmed
pubmed-article:12810867pubmed:authorpubmed-author:YamadaKen-Ich...lld:pubmed
pubmed-article:12810867pubmed:authorpubmed-author:TakasakiTomoh...lld:pubmed
pubmed-article:12810867pubmed:authorpubmed-author:NawaMasaruMlld:pubmed
pubmed-article:12810867pubmed:authorpubmed-author:AkatsukaToshi...lld:pubmed
pubmed-article:12810867pubmed:issnTypePrintlld:pubmed
pubmed-article:12810867pubmed:volume84lld:pubmed
pubmed-article:12810867pubmed:ownerNLMlld:pubmed
pubmed-article:12810867pubmed:authorsCompleteYlld:pubmed
pubmed-article:12810867pubmed:pagination1737-41lld:pubmed
pubmed-article:12810867pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:meshHeadingpubmed-meshheading:12810867...lld:pubmed
pubmed-article:12810867pubmed:year2003lld:pubmed
pubmed-article:12810867pubmed:articleTitleInterference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine.lld:pubmed
pubmed-article:12810867pubmed:affiliationDepartment of Microbiology, Saitama Medical School, 38 Moroyama, Saitama 350-0495, Japan. mnawa@saitama-med.ac.jplld:pubmed
pubmed-article:12810867pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12810867pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12810867lld:pubmed